title: Choice of optimal anticoagulant to support primary PCI: out with the new, in with the old.
authors.affiliation: Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California; and the David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: sanjay.kaul@cshs.org.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
mesh_terms: D000991:Antithrombins / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006629:Hirudins; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D062645:Percutaneous Coronary Intervention; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin
keywords: NACE; STEMI; bleeding; meta-analysis; primary PCI; stent thrombosis